Background. This meta-analysis summarizes the results from recent studies that examined the use of virtual reality (VR)-based interventions on health-related outcomes in patients with cancer, and quantitatively evaluates the efficacy of VR-based interventions. Findings of this meta-analysis can provide direction for future symptom management research. Methods. The search terms included a combination of "virtual reality" OR "virtual environment" OR "head-mounted display" with "oncology" OR "cancer." Three databases (Medline, PubMed, and CAJ Full-text Database), one search engine (Google Scholar), and the website of ResearchGate, covering the period from December 2013 to May 15, 2019, and including articles published in both English and Chinese, were searched. Data synthesis used the RevMan 5.3 to generate pooled estimates of effect size. Results. A total of 6 empirical studies met the eligibility criteria. VR-based interventions had statistically significant effects on reducing symptoms of anxiety, depression, pain, and cognitive function, whereas statistically significant benefit was observed for fatigue (Z = 2.76, P = .006). Conclusion. Most recent studies have primarily examined VR-based interventions for symptom management in the acute stages of cancer care. However, the management of late and long-term side effects is central to cancer survivorship care. There is burgeoning empirical support for further research to evaluate the efficacy of VR-based interventions in cancer rehabilitation.
Introduction
The incidence of cancer is increasing globally and the 5-year relative survival rate for individuals with cancer is 67%. 1 As more cancer patients live longer after treatment, long-term or late effects of cancer and its treatment are more commonly seen in cancer survivors. 2 The long-term side effects of cancer and cancer treatment may include a number of physical and psychological consequences, such as pain, fatigue, anxiety, depression, and cognitive dysfunction. [3] [4] [5] Psychological distress has been found to be negatively associated with cognitive function in cancer patients. [4] [5] [6] Research has also found that cancer-related fatigue and mood changes, such anxiety and depression, significantly affect cancer patients' cognitive functioning and lower their quality of life. 7, 8 Due to recent technology advancements, the development and application of modern technology in the health care field offers new and noninvasive approaches for cancer-related symptom management. 9 Virtual reality (VR) includes a computer capable of real-time animation, controlled by a set of sensory input devices, a position tracker, and a head-mounted device for visual output. 10 There is growing interest in the use of VR-based therapies in multidisciplinary symptom management to address pain reduction, cancer-related fatigue, anxiety, depression, and cognitive dysfunction. [11] [12] [13] While 2 recent reviews have synthesized VR exercises for anxiety and depression management or VR as a distractive intervention to relieve pain and distress during medical procedures, 14, 15 neither of these recent reviews focused on the cancer population. A single older review was previously published that described the use of VR-based interventions in cancer care, but this review only included reports published prior to December 2013. 9 Therefore, the aim of this meta-analysis was to report on the most recent studies using VR-based interventions for symptom management in patients with cancer, and to quantitatively evaluate the efficacy of VR-based intervention in cancer-related symptom management. Findings of this meta-analysis can provide direction for future research.
Methods
The search terms included a combination of "virtual reality" OR "virtual environment" OR "head-mounted display" with "oncology" OR "cancer." These search terms used in this meta-analysis were identified from previous studies' titles and abstracts. Three databases (Medline, PubMed, and CAJ Full-text Database), one search engine (Google Scholar), and the website of ResearchGate, covering the period from December 2013 to May 15, 2019 , and including articles published in both English and Chinese, were searched. Inclusion criteria were patients who were diagnosed with adult-onset (aged 18 years or older) cancer. Interventions included were any type of VR-based interventions (immersive and nonimmersive virtual environment) for cancer patients. Types of studies included randomized controlled or case-controlled trials, and quasi-experimental studies. For each study, data were extracted from the original article by the first author (YZ), then independently verified by a co-investigator (JZ). Disagreements were resolved by a third author. Data synthesis used the Cochrane Collaboration Review Manager (RevMan 5.3; https://com munity.cochrane.org/help/tools-and-software/revman-5) to generate pooled estimates of effect size.
This meta-analysis used the 8-item quality scale to assess risk of bias of each included study. This tool was developed and used in previous studies 15, 16 : these items including whether randomization procedure adequately described or not; with control group or not; outcomes measured before and after the intervention; retention-dropouts less than 30%; missing data analysis conducted; whether power analysis was conducted to determine the appropriate sample size; and with follow-up assessment or not. Each item was rated either as "positive" (low risk of bias) or "negative" (high risk of bias), the total score for each included study was summarized across all positive scores. A median score of 4.5 or above within each study was considered as "high quality and at low risk of bias." 15, 16 
Results

Study Selection and Characteristics
Of the 293 studies identified through searching the 3 databases, 6 studies were eligible for the meta-analysis. Figure 1 shows the article search process and final study selection results.
The characteristics of the included studies are shown in Table 1 . Of the 6 studies, 1 was a randomized controlled trial, 17 1 was a case-controlled trial, 13 and the others were mainly a pre-post-test study design with a single arm. 11, 12, 18, 19 In terms of study settings, only 2 studies were conducted at outpatient cancer care centers, while the others were conducted in hospital inpatient settings. The number of subjects ranged from 6 to 97. All participants were adult cancer patients/survivors. VR interventions included both immersive and nonimmersive formats and the duration of the interventions varied from 30 minutes to 16 weeks. All studies examined the effects of VR-based interventions on health-related outcomes, including anxiety, depression, fatigue, pain reduction, cognitive function, and physical fitness.
Quality and Risk of Bias Assessment
This meta-analysis used the 8-item quality and risk of bias assessment tool suggested by Zeng and colleagues. 15 Table 2 presents the results of the rating scores of each study. Only 1 study had a low risk of bias. 17 All of the other studies had a high risk of bias, most frequently due to the following: no randomization, no power analysis to calculate the appropriate sample size, missing information to discuss strategies to deal with missing data, and a lack of follow-up assessment ( Table 2) . Figure 6 and 7 indicate that the VR-based interventions had favorable effects in improving cancer patients' cognitive function in verbal memory and processing speed, but there were no statistically significant differences (both P > .05).
Overview of VR-Based Interventions to Relieve Cancer-Related Symptoms
Discussion
This updated meta-analysis synthesized the pooled effect of current VR-based interventions in cancer care. Consistent with previous research, 14 VR-based interventions improve cancer patients' emotional, cognitive, and physical well-being. Findings of this review indicate that VR-based interventions result in significant improvement in cancer-related symptoms of fatigue. This meta-analysis also found that other cancer-related symptom management issues, such as anxiety, depression, pain, and cognitive dysfunction, favor VR-based interventions, although there are no statistically significant differences, possibly due to the small sample sizes of the studies that were included.
Compared with traditional symptom-management interventions in cancer care, VR-based interventions, especially VR-based cognitive training, can allow cancer patients to learn. VR-based interventions offer instantaneous feedback on patient performance and then adjust the difficulty level to suit patient needs. 20, 21 In addition, VR-based interventions incorporate the latest real-time graphics and imaging technology, allowing patients to experience numerous visual and auditory stimuli in a computer-generated virtual environment for their rehabilitative needs. 21 Most of the recent studies included in this meta-analysis applied VR-based interventions to patients in an acute stage of cancer care. As the management of late and long-term side-effects is central to cancer survivorship care, it will be important to examine the efficacy of this therapeutic modality for symptom management in cancer survivors. This meta-analysis offers most updated quantitative evidence of efficacy for current VR-based interventions in cancer care. However, the interpretability and generalizability of the findings are limited by inclusion of a small number of studies given the novelty of this approach, generally small sample sizes, and heterogeneous study design (including data from single-arm studies). This meta-analysis excluded qualitative studies on cancer patients' experiences or perceptions of VR-based interventions in symptom management, as these types of studies were beyond the aim of this review. Furthermore, the efficacy of VR-based interventions on cancer-related symptom management should be interpreted with caution. The studies that were included had relatively low methodological quality, indicating the need for studies with robust research design and sample size when conducting further investigations in this area. Last but not least, few of the studies included in this review evaluated the adverse effects of VR-based interventions, with a paucity of research assessing VR-related symptoms, such as the motion sickness effect. 11 This is an important issue, since VR is not without complications. Thus, future research is required to address these knowledge gaps, and long-term cancer survivors should be included as an additional target study population, in order to go beyond the acute stage of cancer symptom management.
Conclusion
This meta-analysis quantitatively pooled the effects of VR-based interventions in cancer-related symptom management. While the findings of this meta-analysis favor VR-based interventions, there is statistical significance only for the outcome of fatigue. Most recent studies have mainly applied VR-based interventions to the symptom management of patients in the acute stages of cancer care. However, the management of late and long-term side effects is central to cancer survivorship care. More research should be conducted to examine the efficacy of VR-based interventions in cancer rehabilitation. Future trials using this therapeutic modality would benefit from using randomized controlled trial designs, larger number of subjects, eligibility criteria that include presence of the symptom that is being treated, and longitudinal pre-post treatment designs.
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